IP Library › Granted Patent US 12,494,676
Granted Patent B2
US 12,494,676 · App. 18/735,802 · Granted Dec 9, 2025

System and method for wirelessly charging a medical device battery

Inventors: Sean Christopher Laughery (Vicksburg, MI); Bryan Christian Mohney (Schoolcraft, MI); Burton Connor Judson (Kalamazoo, MI); Daniel Scott Gunnett (Portage, MI)
Assignee: Stryker Corporation
H02J50/402H02J7/00045H02J7/0045H02J7/0047H02J50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,494,676
App. No.
18/735,802
Filed
Jun 6, 2024
Granted
Dec 9, 2025
Kind
B2
Art Unit
2859
USPC
320/113
Abstract

A system for charging a battery is provided. The system including a battery, a sterile barrier for encasing the battery, a charging device including a charging bay, and a charging controller. The battery includes a battery controller. The charging bay includes a first antenna for establishing communication with a battery controller of the battery encased in the sterile barrier in response to the battery being within a proximity of the charging bay and a second antenna for providing charging power to the battery encased in the sterile barrier. The charging controller detects whether the first antenna has established communication with the battery in response to the battery being within the proximity of the charging bay and provides charging power to the battery via the second antenna in response to detecting that the first antenna has established communication with the battery.

Claims (58)

1 . A system for charging a battery, the system comprising:

one or more batteries, each battery comprising a battery controller;

one or more sterile barriers for encasing the one or more batteries, such that a battery of the one or more batteries is encased in a sterile barrier of the one or more sterile barriers; and

a charging device comprising:

one or more charging bays, each charging bay comprising:

a first antenna configured to establish communication with a battery controller of the battery encased in the sterile barrier in response to the battery being within a proximity of the charging bay; and

a second antenna configured to provide charging power to the battery encased in the sterile barrier; and

a charging controller configured to:

detect whether the first antenna has established communication with the battery in response to the battery being within the proximity of the charging bay; and

provide charging power to the battery via the second antenna in response to detecting that the first antenna has established communication with the battery.

2 . The system of claim 1 , wherein the sterile barrier includes at least one of a sterilizable wrap and an autoclavable container.

3 . The system of claim 1 , wherein the sterile barrier is configured to provide a sterile volume while the sterile barrier remains microbially sealed, and wherein the second antenna is configured to provide charging power to the battery encased within the sterile barrier while the sterile barrier remains microbially sealed.

4 . The system of claim 1 , wherein the battery comprises a visual indicator that indicates a characteristic of the battery, and wherein a portion of the sterile barrier is at least partially transparent to enable the visual indicator to be visible through the portion of the sterile barrier when the battery is encased within the sterile barrier and the sterile barrier remains microbially sealed.

5 . The system of claim 1 , wherein the charging device comprises a switching element that enables the charging controller to selectively activate and deactivate the first antenna and the second antenna, and wherein the charging controller is configured to control the switching element to:

deactivate the second antenna while the first antenna establishes communication with the battery controller; and

deactivate the first antenna while the second antenna provides charging power to the battery.

6 . A system for charging a battery, the system comprising:

a battery comprising a passive communication device and a battery controller coupled to the passive communication device, the battery controller being configured to place the battery in a low-power state;

a sterile barrier for encasing the battery; and

a charging device comprising:

a charging bay comprising:

one or more antennas configured to:

energize the passive communication device of the battery and establish communication with the battery controller via the energized passive communication device; and

provide charging power to the battery; and

a charging controller configured to:

control the one or more antennas to energize the passive communication device of the battery and establish communication with the battery controller via the energized passive communication device such that the battery controller causes the battery to exit the low-power state in response to communication being established;

receive authentication data to authenticate the battery via the established communication in response to the battery controller causing the battery to exit the low-power state; and

provide charging power to the battery via the one or more antennas in response to authenticating the battery.

7 . The system of claim 6 , wherein the sterile barrier includes at least one of a sterilizable wrap and an autoclavable container.

8 . The system of claim 6 , wherein the low-power state is further defined as a power state in which at least some portions of the battery are disabled and the battery consumes less power than in a full power state in which all portions of the battery are enabled.

9 . The system of claim 6 , wherein the battery comprises a visual indicator that indicates a characteristic of the battery, and wherein a portion of the sterile barrier is at least partially transparent to enable the visual indicator to be visible through the portion of the sterile barrier when the battery encased within the sterile barrier and while the sterile barrier remains microbially sealed.

10 . The system of claim 6 , wherein the sterile barrier is configured to provide a sterile volume while the sterile barrier remains microbially sealed, and wherein the charging device is configured to provide charging power to the battery encased within the sterile barrier while the sterile barrier remains microbially sealed.

11 . A method of operating a system for charging a battery, the system including one or more batteries, one or more sterile barriers, and a charging device, wherein each battery includes a battery controller, wherein the charging device includes one or more charging bays and a charging controller, wherein each charging bay includes a first antenna and a second antenna, and wherein the method comprises steps of:

encasing a battery of the one or more batteries in a sterile barrier of the one or more sterile barriers;

placing the battery within a proximity of the charging bay;

establishing, with the first antenna, communication with a battery controller of the battery encased in the sterile barrier in response to the battery being within a proximity of the charging bay;

detecting, with the charging controller, whether the first antenna has established communication with the battery in response to the battery being within the proximity of the charging bay; and

providing, with the charging controller, charging power to the battery encased in the sterile barrier via the second antenna in response to detecting that the first antenna has established communication with the battery.

12 . The method of claim 11 , wherein the sterile barrier includes at least one of a sterilizable wrap and an autoclavable container.

13 . The method of claim 11 , wherein the method further comprises steps of:

providing, with the sterile barrier, a sterile volume while the sterile barrier remains microbially sealed; and

providing, with the second antenna, charging power to the battery encased within the sterile barrier while the sterile barrier remains microbially sealed.

14 . The method of claim 11 , wherein the battery comprises a visual indicator that indicates a characteristic of the battery, and wherein a portion of the sterile barrier is at least partially transparent to enable the visual indicator to be visible through the portion of the sterile barrier when the battery is encased within the sterile barrier and the sterile barrier remains microbially sealed.

15 . The method of claim 11 , wherein the charging device comprises a switching element and wherein the method further comprises steps of:

controlling, with the charging controller, the switching element to deactivate the second antenna while the first antenna establishes communication with the battery controller; and

controlling, with the charging controller, the switching element to deactivate the first antenna while the second antenna provides charging power to the battery.

16 . A method of operating a system for charging a battery, the system including a battery, a sterile barrier, and a charging device, wherein each battery includes a passive communication device and a battery controller, wherein the charging device includes a charging bay and a charging controller, wherein each charging bay includes one or more antennas, and wherein the method comprises steps of:

placing, with the battery controller, the battery in a low-power state;

encasing the battery in the sterile barrier;

controlling, with the charging controller, the one or more antennas to energize the passive communication device of the battery and establish communication with the battery controller via the energized passive communication device such that the battery controller causes the battery to exit the low-power state in response to communication being established;

receiving, with the charging controller, authentication data to authenticate the battery via the established communication in response to the battery controller causing the battery to exit the low-power state; and

providing, with charging controller, charging power to the battery via the one or more antennas in response to authenticating the battery.

17 . The method of claim 16 , wherein the sterile barrier includes at least one of a sterilizable wrap and an autoclavable container.

18 . The method of claim 16 , wherein the low-power state is further defined as a power state in which at least some portions of the battery are disabled and the battery consumes less power than in a full power state in which all portions of the battery are enabled.

19 . The method of claim 16 , wherein the battery comprises a visual indicator that indicates a characteristic of the battery, and wherein a portion of the sterile barrier is at least partially transparent to enable the visual indicator to be visible through the portion of the sterile barrier when the battery encased within the sterile barrier and while the sterile barrier remains microbially sealed.

20 . The method of claim 16 , wherein the method further comprises steps of:

providing, with the sterile barrier, a sterile volume while the sterile barrier remains microbially sealed; and

providing, with the one or more antennas, charging power to the battery encased within the sterile barrier while the sterile barrier remains microbially sealed.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2024
From: LAUGHERY, SEAN CHRISTOPHER; MOHNEY, BRYAN CHRISTIAN; JUDSON, BURTON CONNOR; GUNNETT, DANIEL SCOTT
To: STRYKER CORPORATION
Reel/Frame 069245/0854 →
Continuity (4)
Continuation 18056576 · Nov 17, 2022
Continuation 16651246
Provisional Application 62563245 · Sep 26, 2017
Related Publication 20240322610A1 · Sep 26, 2024
References Cited (191)
US 645576A · Trower et al. · 1900 [cited by applicant]
US 3861873A · MacFarlane et al. · 1975 [cited by applicant]
US 5183643A · Nichols · 1993 [cited by applicant]
US 5225767A · Gulczynski · 1993 [cited by applicant]
US 5455466A · Parks et al. · 1995 [cited by applicant]
US 5734254A · Stephens · 1998 [cited by applicant]
US 5744933A · Inoue et al. · 1998 [cited by applicant]
US 5952814A · Van Lerberghe · 1999 [cited by applicant]
US 6018227A · Kumar et al. · 2000 [cited by applicant]
US 6118249A · Brockmann et al. · 2000 [cited by applicant]
US 6184651B1 · Fernandez et al. · 2001 [cited by applicant]
US 6184655B1 · Malackowski · 2001 [cited by applicant]
US 6301128B1 · Jang et al. · 2001 [cited by applicant]
US 6379631B1 · Wu · 2002 [cited by applicant]
US 6605922B2 · Tamai et al. · 2003 [cited by applicant]
US 6844702B2 · Giannopoulos et al. · 2005 [cited by applicant]
US 6847190B2 · Schaefer et al. · 2005 [cited by applicant]
US 7501198B2 · Barlev et al. · 2009 [cited by applicant]
US 7705559B2 · Powell et al. · 2010 [cited by applicant]
US 7948208B2 · Partovi et al. · 2011 [cited by applicant]
US 8169185B2 · Partovi et al. · 2012 [cited by applicant]
US 8183827B2 · Lyon · 2012 [cited by applicant]
US 8258745B2 · Smith et al. · 2012 [cited by applicant]
US 8278873B2 · Smith et al. · 2012 [cited by applicant]
US 8344690B2 · Smith et al. · 2013 [cited by applicant]
US 8344691B2 · Smith et al. · 2013 [cited by applicant]
US 8418872B2 · Smith · 2013 [cited by applicant]
US 8431153B2 · Shukla · 2013 [cited by applicant]
US 8432293B2 · Symons · 2013 [cited by applicant]
US 8508378B2 · Ross et al. · 2013 [cited by applicant]
US 8519668B2 · Hui · 2013 [cited by applicant]
US 8567048B2 · Singh et al. · 2013 [cited by applicant]
US 8590724B2 · Kreidler et al. · 2013 [cited by applicant]
US 8594567B2 · Finkenzeller et al. · 2013 [cited by applicant]
US 8629652B2 · Partovi et al. · 2014 [cited by applicant]
US 8638062B2 · Baarman et al. · 2014 [cited by applicant]
US 8803475B2 · Smith et al. · 2014 [cited by applicant]
US 8808283B2 · Moua et al. · 2014 [cited by applicant]
US 8810197B2 · Juergens · 2014 [cited by applicant]
US 8890470B2 · Partovi · 2014 [cited by applicant]
US 8901779B2 · Kesler et al. · 2014 [cited by applicant]
US 8947047B2 · Partovi et al. · 2015 [cited by applicant]
US 9000720B2 · Stulen et al. · 2015 [cited by applicant]
US 9024576B2 · Maenpaa · 2015 [cited by applicant]
US 9106203B2 · Kesler et al. · 2015 [cited by applicant]
US 9124121B2 · Ben-Shalom et al. · 2015 [cited by applicant]
US 9131034B2 · Ma et al. · 2015 [cited by applicant]
US 9136729B2 · Ashinghurst et al. · 2015 [cited by applicant]
US 9142989B2 · Fell et al. · 2015 [cited by applicant]
US 9143003B2 · Baarman et al. · 2015 [cited by applicant]
US 9178369B2 · Partovi · 2015 [cited by applicant]
US 9178569B2 · Chakravarty et al. · 2015 [cited by applicant]
US 9209634B2 · Cottrill et al. · 2015 [cited by applicant]
US 9248205B2 · Smith et al. · 2016 [cited by applicant]
US 9276437B2 · Partovi et al. · 2016 [cited by applicant]
US 9301718B2 · Lin · 2016 [cited by applicant]
US 9327041B2 · Hawkes · 2016 [cited by applicant]
US 9364288B2 · Smith et al. · 2016 [cited by applicant]
US 9381058B2 · Houser et al. · 2016 [cited by applicant]
US 9472966B2 · Frushour et al. · 2016 [cited by applicant]
US 9554411B1 · Hall · 2017 [cited by examiner]
US 9583803B2 · Miller et al. · 2017 [cited by applicant]
US 9590446B2 · Park et al. · 2017 [cited by applicant]
US 9597143B2 · Madan et al. · 2017 [cited by applicant]
US 9601943B2 · Partovi et al. · 2017 [cited by applicant]
US 9667091B2 · Baek et al. · 2017 [cited by applicant]
US 9680335B2 · Kang et al. · 2017 [cited by applicant]
US 9707395B2 · Marnfeldt et al. · 2017 [cited by applicant]
US 9711999B2 · Hietala et al. · 2017 [cited by applicant]
US 9722447B2 · Partovi · 2017 [cited by applicant]
US 9750930B2 · Chen · 2017 [cited by applicant]
US 9824815B2 · Leabman et al. · 2017 [cited by applicant]
US 9831705B2 · Von Novak et al. · 2017 [cited by applicant]
US 9837862B2 · Sherman et al. · 2017 [cited by applicant]
US 9842686B2 · Peterson et al. · 2017 [cited by applicant]
US 9847677B1 · Leabman et al. · 2017 [cited by applicant]
US 9866051B2 · Peterson · 2018 [cited by applicant]
US 9872723B2 · Smith · 2018 [cited by applicant]
US 9876380B1 · Leabman et al. · 2018 [cited by applicant]
US 9929584B2 · Aghassian et al. · 2018 [cited by applicant]
US 9941590B2 · Luzinski et al. · 2018 [cited by applicant]
US 9948128B2 · Ashinghurst et al. · 2018 [cited by applicant]
US 10004911B2 · Marnfeldt et al. · 2018 [cited by applicant]
US 10044229B2 · Partovi et al. · 2018 [cited by applicant]
US 10056790B2 · Miller et al. · 2018 [cited by applicant]
US 10063105B2 · Leabman · 2018 [cited by applicant]
US 10115520B2 · Partovi · 2018 [cited by applicant]
US 10117184B2 · Fukaya · 2018 [cited by applicant]
US 10236709B2 · Decker et al. · 2019 [cited by applicant]
US 10250066B2 · Jankins et al. · 2019 [cited by applicant]
US 10284023B2 · Kim et al. · 2019 [cited by applicant]
US 10312722B2 · Decker et al. · 2019 [cited by applicant]
US 10375639B2 · Tsukamoto · 2019 [cited by applicant]
US 10396606B2 · Hall et al. · 2019 [cited by applicant]
US 10468904B2 · Decker et al. · 2019 [cited by applicant]
US 10862317B2 · Loncarevic · 2020 [cited by applicant]
US 11575281B2 · Laughery · 2023 [cited by examiner]
US 12034315B2 · Laughery · 2024 [cited by examiner]
US 20030102842A1 · Tamai et al. · 2003 [cited by applicant]
US 20040145342A1 · Lyon · 2004 [cited by applicant]
US 20070090025A1 · Strand · 2007 [cited by applicant]
US 20070090788A1 · Hansford et al. · 2007 [cited by applicant]
US 20110279226A1 · Chen et al. · 2011 [cited by applicant]
US 20120116380A1 · Madan et al. · 2012 [cited by applicant]
US 20120116381A1 · Houser et al. · 2012 [cited by applicant]
US 20120306281A1 · Bohori et al. · 2012 [cited by applicant]
US 20130300204A1 · Partovi · 2013 [cited by applicant]
US 20140074185A1 · Fell et al. · 2014 [cited by applicant]
US 20140132210A1 · Partovi · 2014 [cited by applicant]
US 20140276665A1 · Lopez et al. · 2014 [cited by applicant]
US 20140327390A1 · Park et al. · 2014 [cited by applicant]
US 20140347233A1 · Mahanfar et al. · 2014 [cited by applicant]
US 20140350545A1 · Moua et al. · 2014 [cited by applicant]
US 20150088115A1 · Smith · 2015 [cited by applicant]
US 20150102681A1 · Leabman et al. · 2015 [cited by applicant]
US 20150180284A1 · Kang et al. · 2015 [cited by applicant]
US 20150326059A1 · Abu Qahouq · 2015 [cited by applicant]
US 20150365136A1 · Miller et al. · 2015 [cited by applicant]
US 20160072328A1 · Cottrill et al. · 2016 [cited by applicant]
US 20160079800A1 · Ashinghurst et al. · 2016 [cited by applicant]
US 20160087483A1 · Hietala et al. · 2016 [cited by applicant]
US 20160111886A1 · Sherman et al. · 2016 [cited by applicant]
US 20160126771A1 · Aghassian et al. · 2016 [cited by applicant]
US 20160134140A1 · Tittle et al. · 2016 [cited by applicant]
US 20160181821A1 · Xu et al. · 2016 [cited by applicant]
US 20160181854A1 · Leabman · 2016 [cited by applicant]
US 20160190856A1 · Baek · 2016 [cited by examiner]
US 20160192989A1 · Aman · 2016 [cited by examiner]
US 20160249910A1 · Shelton, IV et al. · 2016 [cited by applicant]
US 20160249918A1 · Shelton, IV et al. · 2016 [cited by applicant]
US 20160254694A1 · Peterson et al. · 2016 [cited by applicant]
US 20160310077A1 · Hunter et al. · 2016 [cited by applicant]
US 20160329614A1 · Madan et al. · 2016 [cited by applicant]
US 20160338760A1 · Houser et al. · 2016 [cited by applicant]
US 20160352134A1 · Pawar et al. · 2016 [cited by applicant]
US 20170070067A1 · Suzuki et al. · 2017 [cited by applicant]
US 20170085112A1 · Leabman · 2017 [cited by applicant]
US 20170110889A1 · Bell et al. · 2017 [cited by applicant]
US 20170179763A9 · Leabman et al. · 2017 [cited by applicant]
US 20170324267A1 · Decker · 2017 [cited by examiner]
US 20170331318A1 · Jankins · 2017 [cited by examiner]
US 20170360976A1 · Thomas et al. · 2017 [cited by applicant]
US 20180131238A1 · Leabman · 2018 [cited by applicant]
US 20180372806A1 · Laughery et al. · 2018 [cited by applicant]
US 20200280219A1 · Laughery et al. · 2020 [cited by applicant]
US 20230079910A1 · Laughery et al. · 2023 [cited by applicant]
CA 2895640A1 · 2016 [cited by applicant]
CN 101636892A · 2010 [cited by applicant]
CN 104242385A · 2014 [cited by applicant]
CN 104838599A · 2015 [cited by applicant]
DE 3734120A1 · 1989 [cited by applicant]
DE 10109358C1 · 2002 [cited by applicant]
DE 102014112544A1 · 2016 [cited by applicant]
EP 1684396A2 · 2006 [cited by applicant]
EP 2705876A1 · 2014 [cited by applicant]
EP 2763279A1 · 2014 [cited by applicant]
EP 2849353A1 · 2015 [cited by applicant]
EP 2851017A1 · 2015 [cited by applicant]
EP 3098937A1 · 2016 [cited by applicant]
EP 3136544A1 · 2017 [cited by applicant]
EP 3242376A1 · 2017 [cited by applicant]
EP 3244509A1 · 2017 [cited by applicant]
JP 2005043059A · 2005 [cited by applicant]
JP 2014204654A · 2014 [cited by applicant]
JP 2017085700A · 2017 [cited by applicant]
JP 2017085711A · 2017 [cited by applicant]
KR 20120123384A · 2012 [cited by applicant]
WO 03105308A1 · 2003 [cited by applicant]
WO 2006018231A1 · 2006 [cited by applicant]
WO 2007050439A2 · 2007 [cited by applicant]
WO 2012061635A1 · 2012 [cited by applicant]
WO 2013014878A1 · 2013 [cited by applicant]
WO 2016044651A1 · 2016 [cited by applicant]
WO 2016118316A1 · 2016 [cited by applicant]
WO 2016187295A1 · 2016 [cited by applicant]
WO 2018154138A1 · 2018 [cited by applicant]
WO 2018192875A1 · 2018 [cited by applicant]
English language abstract and machine-assisted English translation for CN 104242385 A extracted from espacenet.com database on Mar. 30, 2023, 21 pages. [cited by applicant]
English language abstract and machine-assisted English translation for DE 101 09 358 extracted from espacenet.com database on May 11, 2020, 8 pages. [cited by applicant]
English language abstract and machine-assisted English translation for DE 37 34 120 extracted from espacenet.com database on May 11, 2020, 6 pages. [cited by applicant]
English language abstract and machine-assisted English translation for JP 2005-043059 A extracted from espacenet.com database on Jun. 20, 2023, 16 pages. [cited by applicant]
English language abstract and machine-assisted English translation for WO 2018/192875 extracted from espacenet.com database on May 11, 2020, 11 pages. [cited by applicant]
English language abstract for CN 101636892 A extracted from espacenet.com database on Mar. 30, 2023, 2 pages. [cited by applicant]
English language abstract for CN104838599 A extracted from espacenet.com database on Mar. 30, 2023, 1 page. [cited by applicant]
English language abstract for KR 202-0123384 A extracted from espacenet.com database on Jun. 20, 2023, 2 pages. [cited by applicant]
English language abstract for WO 2006/018231 extracted from espacenet.com database on May 11, 2020, 2 pages. [cited by applicant]
International Search Report for Application No. PCT/US2018/052854 dated Jan. 7, 2019, 4 pages. [cited by applicant]
Machine-assisted English language abstract and machine-assisted English translation for DE 10 2014 112 544 extracted from espacenet.com database on May 11, 2020, 10 pages. [cited by applicant]
English language abstract and machine-assisted English translation for JP 2014-204654 A extracted from espacenet. com database on Jul. 18, 2025, 24 pages. [cited by applicant]
English language abstract for JP 2017-085711 A extracted from espacenet.com database on Jul. 18, 2025, 2 pages. [cited by applicant]
English language abstract for JP 2017-085700 A extracted from espacenet.com database on Jul. 18, 2025, 2 pages. [cited by applicant]